A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 149
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ATV
Long Form : atorvastatin
No. Year Title Co-occurring Abbreviation
2019 Access and concentrations of atorvastatin in the prostate in men with prostate cancer. ATV-Lactone
2019 Application of ultrasound-guided cholecystocentesis to the evaluation of the metabolite profiling in bile of dogs and cynomolgus monkeys. BDC, UCC
2019 Atorvastatin downregulates HSP22 expression inanatherosclerotic model in vitro and in vivo. HFD, HSP22, HUVECs, MAPK
2019 Atorvastatin Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells Derived Exosomes in Acute Myocardial Infarction via Up-regulating Long Non-coding RNA H19. AMI, MSCs
2019 Atorvastatin improves the cardiac function of rats after acute myocardial infarction through ERK1/2 pathway. AMI, ECG, ERK, HE, LVWI, MRI, mRNA, PCR, SD, TUNEL
2019 Atorvastatin Inhibited ROS Generation and Increased IL-1beta And IL-6 Release by Mononuclear Cells from Diabetic Patients. HMG-CoA, iPKCbeta, PBMNC, T2DM
2019 Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus. NP, ROS
2019 Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by activating SDF-1/CXCR4 axis. ATV-MSCs, MSCs
2019 Efficacy and adverse reaction to different doses of atorvastatin in the treatment of type II diabetes mellitus. ALT, apoB, AST, BUN, CETP, Cr, RBP4, TG
10  2019 Efficacy of locally-delivered statins adjunct to non-surgical periodontal therapy for chronic periodontitis: a Bayesian network analysis. CAL, CP, IBD, MD, PD, RCTs, SMV, SRP
11  2019 Gliclazide alone or in combination with atorvastatin ameliorated reproductive damage in streptozotocin-induced type 2 diabetic male rats. GLZ, STZ
12  2019 High concentrations of atorvastatin reduce in-vitro function of conventional T and regulatory T cells. FoxP3, IL, PD-1, TNF
13  2019 Optimization of Timing and Times for Administration of Atorvastatin-Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction. AMI, LVEF, MSCs, SDF-1
14  2019 P-AKT2/SPK1 (P-SPK1) and P-MEK/P-ERK cell signaling pathways are involved in LPS-induced macrophage migration. P-SPK1
15  2019 Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: Application in a clinical pharmacokinetic study of single oral dose. LAC, o-OH-ATV, p-OH-ATV
16  2019 Simultaneous LC-MS/MS analysis of simvastatin, atorvastatin, rosuvastatin and their active metabolites for plasma samples of obese patients underwent gastric bypass surgery. GBS, RSV, SMV, SMV-A, SRM
17  2019 Tongxinluo Ameliorates Myocardial Ischemia-Reperfusion Injury Mainly via Activating Parkin-Mediated Mitophagy and Downregulating Ubiquitin-Proteasome System. CQ, cTnI, MIRI, PINK1
18  2019 Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial. RTOG, VAS
19  2019 Trastuzumab Induced Chemobrain, Atorvastatin Rescued Chemobrain with Enhanced Anticancer Effect and without Hair Loss-Side Effect. MRI, PET, TZB
20  2018 Atorvastatin alters gene expression and cholesterol synthesis in primary rainbow trout (Oncorhynchus mykiss) hepatocytes. ---
21  2018 Atorvastatin attenuates the ovarian damage induced by cyclophosphamide in rat: An experimental study. CP
22  2018 Atorvastatin mitigates cyclophosphamide-induced hepatotoxicity via suppression of oxidative stress and apoptosis in rat model. AST, CP, LDH, MDA, PC
23  2018 Design and characterization of a perivascular PLGA coated PET mesh sustaining the release of atorvastatin for the prevention of intimal hyperplasia. PLCL, PLGA
24  2018 Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin. AKI, AST, AUC, BSO, CPFX, CPK
25  2018 Imaging the porous structure in the core of degrading PLGA microparticles: The effect of molecular weight. PLGA
26  2018 LDL cholesterol levels after switch from atorvastatin to rosuvastatin. ASCVD, LDL-C, RSV
27  2018 Modeling Statin-Induced Reductions of Cardiovascular Events in Primary Prevention: A VOYAGER Meta-Analysis. ASCVD, CV, RSV
28  2018 Nano-particle engineered atorvastatin delivery to support mesenchymal stem cell survival in infarcted myocardium. ATVNPs, MI, MSC
29  2018 Paradoxical effects of atorvastatin in isoproterenol-induced cardiotoxicity in rats: Role of oxidative stress and inflammation. CK-MB, ISO
30  2018 Photolysis of atorvastatin in aquatic environment: Influencing factors, products, and pathways. LC-TOF-MS, SRFA
31  2018 Porous Polylactide Film Plus Atorvastatin-Loaded Thermogel as an Efficient Device for Peritoneal Adhesion Prevention. PLA
32  2018 Radioprotective effect of atorvastatin against ionizing radiation-induced nephrotoxicity in mice. IR
33  2018 Rapid quantitation of atorvastatin in process pharmaceutical powder sample using Raman spectroscopy and evaluation of parameters related to accuracy of analysis. ---
34  2017 1.2% Rosuvastatin and 1.2% Atorvastatin Gel Local Drug Delivery and Redelivery in the Treatment of Class II Furcation Defects: A Randomized Controlled Clinical Trial. CAL, DDR, PD, RSV, SRP
35  2017 Atorvastatin Attenuates Ischemia/Reperfusion-Induced Hippocampal Neurons Injury Via Akt-nNOS-JNK Signaling Pathway. ---
36  2017 Atorvastatin mitigates testicular injuries induced by ionizing radiation in mice. IR
37  2017 Atorvastatin Pretreatment Inhibits Myocardial Inflammation and Apoptosis in Swine After Coronary Microembolization. CME, cTnI, TNF-alpha
38  2017 Coenzyme Q10 Prevents Mitochondrial Dysfunction and Facilitates Pharmacological Activity of Atorvastatin in 6-OHDA Induced Dopaminergic Toxicity in Rats. DA, LPO, MMP, SNpc, SOD
39  2017 Coenzyme Q10 protects against statin-induced myotoxicity in zebrafish larvae (Danio rerio). CoQ10, HMGCR
40  2017 Comparative evaluation of efficacy of subgingivally delivered 1.2% Atorvastatin and 1.2% Simvastatin in the treatment of intrabony defects in chronic periodontitis: a randomized controlled trial. mSBI, PD, PI, RAL, SMV, SRP
41  2017 Comparative evaluation of subgingivally delivered 1% alendronate versus 1.2% atorvastatin gel in treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. ALN, CAL, IBD, PD, SRP
42  2017 Effect of AGTR1 and BDKRB2 gene polymorphisms on atorvastatin metabolism in a Mexican population. AGTR1, BDKRB2
43  2017 Impurities in Drug Products and Active Pharmaceutical Ingredients. DLX
44  2017 Model design for screening effective Antihyperlipidemic drugs using zebrafish system. EZE, FEF, HFD, LDC
45  2017 Quantitative Analysis of the Transporter-Mediated Drug-Drug Interaction Between Atorvastatin and Rifampicin Using a Stable Isotope-IV Method. AUCpo, DDIs, OATP1B1, RIF
46  2017 Specific Inhibition of the Distribution of Lobeglitazone to the Liver by Atorvastatin in Rats: Evidence for a Rat Organic Anion Transporting Polypeptide 1B2-Mediated Interaction in Hepatic Transport. LB, OATP
47  2017 Specific rescue by ortho-hydroxy atorvastatin of cortical GABAergic neurons from previous oxygen/glucose deprivation: role of pCREB. CREB, NMDA, o-ATV, OGD, pCREB
48  2017 Subgingivally delivered 1.2% atorvastatin in the treatment of chronic periodontitis among smokers: a randomized, controlled clinical trial. CP, IBD, SRP
49  2016 1.2% Rosuvastatin Versus 1.2% Atorvastatin Gel Local Drug Delivery and Redelivery in Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Placebo-Controlled Clinical Trial. CAL, CP, IBDs, LDD, mSBI, PD, PI, RSV, SRP
50  2016 A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers. ---
51  2016 AMPK-mediated cardioprotection of atorvastatin relates to the reduction of apoptosis and activation of autophagy in infarcted rat hearts. AMI, AMPK, mTOR, PCR
52  2016 Anti-inflammatory and Anti-resorptive Effects of Atorvastatin on Alveolar Bone Loss in Wistar Rats. ABL, BALP
53  2016 Atorvastatin in improvement of cognitive impairments caused by amyloid beta in mice: involvement of inflammatory reaction. AD, FPP, LTP
54  2016 Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein. ANA, ApoA, CETP, HDL-C, PBO
55  2016 Conductometric and volumetric studies of atorvastatin in aqueous solution of arginine from 298.15 to 313.15 K. Arg
56  2016 Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets. AML, CE
57  2016 Effects of Atorvastatin on Periodontitis of Rats Subjected to Glucocorticoid-Induced Osteoporosis. BALP, CAT, DKK1, EP, GIOP, IL, MPO, OPG, RANKL, SAL, SOD, TNF
58  2016 Efficacy of Subgingivally Delivered 1.2% Atorvastatin in the Treatment of Chronic Periodontitis in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Clinical Trial. CP, PD, RAL, SRP, T2DM
59  2016 Exposure to gemfibrozil and atorvastatin affects cholesterol metabolism and steroid production in zebrafish (Danio rerio). GEM
60  2016 Increase of Frequency and Modulation of Phenotype of Regulatory T Cells by Atorvastatin Is Associated with Decreased Lung Inflammatory Cell Infiltration in a Murine Model of Acute Allergic Asthma. BAL, IL, MLN, OVA, Th2
61  2016 Inverse relationship between high-density lipoprotein cholesterol raising and high-sensitivity C-reactive protein reduction in older patients treated with lipid-lowering therapy. E/S, HDL, hs-CRP, LDL-C
62  2016 Perivascular sustained release of atorvastatin from a hydrogel-microparticle delivery system decreases intimal hyperplasia. IH, PLGA
63  2016 Platelet-Rich Fibrin Combined With 1.2% Atorvastatin for Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial. CP, IBDs, OFD, PD, PRF, RCAL
64  2015 Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects. apoB, CETP, FCR, PCSK9, PR, PS
65  2015 Assessment of hepatic function, oxidant/antioxidant status, and histopathological changes in rats treated with atorvastatin: Effect of dose and acute intoxication with acetaminophen. MDA, SOD
66  2015 Atorvastatin prevents development of kindling by modulating hippocampal levels of dopamine, glutamate, and GABA in mice. EPM, FST, HLE, ICES, PTZ, TBARS
67  2015 Atorvastatin-induced endothelial nitric oxide synthase expression in endothelial cells is mediated by endoglin. eNOS, HUVECs, siRNA, TGF-beta
68  2015 Comparing protective effect of grape seed extract versus atorvastatin on endometriosis in rat model: Evidence for immunohistochemical and biochemical alterations. GET, GSH-Px, MDA, SOD
69  2015 Evaluation of cynomolgus monkeys for the identification of endogenous biomarkers for hepatic transporter inhibition and as a translatable model to predict pharmacokinetic interactions with statins in humans. AUC, DDIs, OATPs, RIF, RSV
70  2015 Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4. AMI, CXCR4, MSCs, SDF-1
71  2015 The roles of nitric oxide and hydrogen sulfide in the anti-atherosclerotic effect of atorvastatin. CSE, eNOS, LDL-C, qRT-PCR, TC
72  2014 Atorvastatin induces autophagy of mesenchymal stem cells under hypoxia and serum deprivation conditions by activating the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. AVO, MEK/ERK, MSCs
73  2014 Atorvastatin plus omega-3 fatty acid ethyl ester decreases very-low-density lipoprotein triglyceride production in insulin resistant obese men. FCR, PR
74  2014 Dietary alpha-tocopherol and atorvastatin reduce high-fat-induced lipid accumulation and down-regulate CD36 protein in the liver of guinea pigs. alphaT, CD
75  2014 Effects on serum uric acid by difference of the renal protective effects with atorvastatin and rosuvastatin in chronic kidney disease patients. CKD, eGFR, GFR, ROS, SUA
76  2014 GluN2B N-methyl-D-aspartic acid receptor subunit mediates atorvastatin-Induced neuroprotection after focal cerebral ischemia. BDNF
77  2014 Low-dose combination of alendronate and atorvastatin reduces ligature-induced alveolar bone loss in rats. ALD, BALP, MPO, SAL
78  2014 Statins enhance rotator cuff healing by stimulating the COX2/PGE2/EP4 pathway: an in vivo and in vitro study. CEL, PGE2, RC
79  2013 Acute vascular effects of atorvastatin in hypertensive men: a pilot study. ACh, Ang II, EDV, SNP
80  2013 Atorvastatin requires geranylgeranyl transferase-I and Rac1 activation to exert neuronal protection and induce plasticity. AD, FPP, GGPP, Glu
81  2013 Atorvastatin-loaded hydrogel affects the smooth muscle cells of human veins. Cx43, HSMCs, IH, PAI-1
82  2013 Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: a randomized controlled clinical trial. CAL, IBDs, PD, SRP
83  2013 Degradation kinetics of atorvastatin under stress conditions and chemical analysis by HPLC. ---
84  2013 Dyslipidemic drugs in metabolic syndrome. EZE, HDL-C, RSV, TG
85  2013 Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia. ANA, HDL-C, LDL-C
86  2013 High-dose supplementation with natural alpha-tocopherol does neither alter the pharmacodynamics of atorvastatin nor its phase I metabolism in guinea pigs. alpha-T, HFC
87  2013 In vitro dissolution study of atorvastatin binary solid dispersion. PM, POL188, SD, SE
88  2013 Protective role of atorvastatin against doxorubicin-induced cardiotoxicity and testicular toxicity in mice. DOX
89  2013 Role of endothelial nitric oxide synthase and vagal activity in the endothelial protection of atorvastatin in ischemia/reperfusion injury. ACh, I/R
90  2012 Anticancer effect of atorvastatin nanostructured polymeric micelles based on stearyl-grafted chitosan. DS, S-SC, SC
91  2012 Atorvastatin inhibits collar-induced intimal thickening of rat carotid artery: effect on C-type natriuretic peptide expression. CNP, ELISA
92  2012 Atorvastatin inhibits myocardin expression in vascular smooth muscle cells. SM
93  2012 Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway. 3-MA, AMPK, LC3-II, MSCs, mTOR
94  2012 Daming capsule restores endothelial dysfunction induced by high-fat diet. DMC, eNOS, HF
95  2012 Drug-drug interaction study to assess the effects of atorvastatin co-administration on pharmacokinetics and anti-thrombotic properties of cilostazol in male Wistar rats. CLZ
96  2012 Effect of multidose cilostazol on pharmacokinetic and lipid profile of atorvastatin in male Wistar rats. CLZ, RLM
97  2012 Effects of rosuvastatin and atorvastatin on renal function: meta-analysis. CI, GFR, RoM, RSV, SMD
98  2012 Validated spectrophotometric methods for the simultaneous determination of telmisartan and atorvastatin in bulk and tablets. TELM
99  2011 Atorvastatin acts synergistically with N-acetyl cysteine to provide therapeutic advantage against Fas-activated erythrocyte apoptosis during chronic arsenic exposure in rats. NAC, ROS
100  2011 Atorvastatin inhibits functional expression of proatherogenic TLR2 in arterial endothelial cells. HCAEC